Retrospective Study
Copyright ©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1408-1420
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1408
Table 3 Frequency of risk allele of polymorphisms associated with lipid disorders in West Mexican populations
Lipid abnormality
SNPs (risk allele)
Native American ancestry
Mestizos (low-to-high European ancestry)
Total WMX (n = 1324)
P value
NAH (n = 84)
WXK (n = 106)
TPC (n = 184)
GDL (n = 754)
CUQ (n = 131)
VP (n = 32)
SMA (n = 33)
Low HDL-cABCA1 R230C (RC + CC genotypes)15 (17.9)43 (40.6)24 (13.0)53 (7.0)18 (13.7)4 (12.5)2 (6.1)159 (12.0)0.010c
High TCeAPOE (E4 allele)21 (12.5)53 (25.0)ND145 (9.6)ND2 (3.1)2 (3.0)223 (8.4)2 × 10-12a
APOB-516C/T (T allele)49 (29.2)58 (27.4)ND433 (28.7)ND24 (37.5)18 (27.3)582 (22.0)0.129
LDLR A1413G (G allele) 121 (72.0)161 (75.9)ND1045 (69.3)ND42 (65.6)44 (66.7)1413 (53.5)0.047a
LDLR C*52T (C allele)124 (73.8)145 (68.4)ND1068 (70.8)ND55 (85.9)52 (78.8)1444 (54.7)0.045b
High TGeAPOE (E2 allele)0 (0)0 (0)ND51 (3.4)ND1 (1.6)7 (10.6)59 (2.2)0.028d
MTTP-493G/T (T allele)17 (10.1)2 (0.9)ND253 (16.8)ND11 (17.2)10 (15.2)293 (11.1)2 × 10-6b
MTHFR C677T (T allele)103 (61.3)111 (52.4)172 (46.7)670 (44.4)117 (44.6)25 (39.1)21 (31.8)930 (35.2)0.038b